Q1 2013

Source filing unavailable

Q1 2013 · —

Revenue

$19.20K

no prior Q1 2012 on file

Net Income

-$816.37K

no prior Q1 2012 on file

EPS Diluted

-$0.48

no prior Q1 2012 on file

Gross Profit$7,075—

Operating Cash Flow-$592,973—

Free Cash Flowderived

Same quarter

no prior Q1 2012 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR